Status:
RECRUITING
Physiologic Measure of VIPN
Lead Sponsor:
Children's National Research Institute
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
6-18 years
Brief Summary
The purpose of this study is the development of a physiologic endpoint using a novel technology that would provide an objective, easy to use and more sensitive assessment of VIPN in children and adole...
Eligibility Criteria
Inclusion
- 6-18 years of age at the start of the study, are receiving vincristine in DI (clinical study population) and are willing and able to provide informed consent or assent to study participation.
Exclusion
- have eye pathology which precludes pupillometry, are hemodynamically unstable, or are pregnant.
Key Trial Info
Start Date :
September 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04786977
Start Date
September 20 2021
End Date
December 1 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Health System
Washington D.C., District of Columbia, United States, 20010